United States· US:0003-3638_510c2d51-4943-401c-a008-ea22f61c6938

REYATAZ

A atazanavir product containing atazanavir sulfate, registered in United States by E.R. Squibb & Sons, L.L.C.. The same ATC class is registered in 17 of our 19 countries.

ATC J05AE08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedREYATAZATCJ05AE08REGISTER NO.US:0003-3638_510c2d51…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Atazanavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AE08 (atazanavir), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Atazanavir · ATC J05AE08

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atazanavir costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Atazanavir · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$14.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ATAZANAVIR SULFATE
Manufacturer
E.R. Squibb & Sons, L.L.C.
Country
United States (US)
ATC code
J05AE08
ATC class
Atazanavir
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0003363810
    30 PACKET in 1 CARTON (0003-3638-10) / 1 POWDER in 1 PACKET
  • ndc11
    0003-3638-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

429 interactions on record for atazanavir.

Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atazanavir · interactions on record

429 records

  • 135 severe
  • 204 moderate
  • 14 minor
  • 50 info

Most severe, free to view

  • CimetidineA02BA01severe
  • RanitidineA02BA02severe
  • FamotidineA02BA03severe
  • NizatidineA02BA04severe

26 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atazanavir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atazanavir products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Cyprus · Atazanavir Remedica
  • Czechia · Atazanavir Accord
  • Germany · Atazanavir Accord, Atazanavir Al
  • Denmark · Atazanavir Stada
  • Spain · Atazanavir Stada, Atazanavir Teva
  • Finland · Atazanavir Stada
  • France · Atazanavir Arrow, Atazanavir Biogaran
  • United Kingdom (Northern Ireland) · Atazanavir Accord, Atazanavir Amarox
  • Croatia · Atazanavir Accord
  • Ireland · Atazanavir Rowex
  • Iceland · Atazanavir Stada, Atazanavir Stada 150 Mg Hörð Hylki
  • Italy · Atazanavir Sandoz
  • Liechtenstein · Atazanavir Viatris, Reyataz
  • Latvia · Atazanavir Sandoz
  • Netherlands · Atazanavir Accord, Atazanavir Medicopharm
  • Norway · Atazanavir Viatris, Reyataz
  • Portugal · Atazanavir Farmoz, Atazanavir Generis
  • Romania · Atazanavir Stada, Atazanavir Teva
  • Sweden · Atazanavir Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad07355d-b613-4236-b7d9-241b35a08da0
GET /v1/drugs/ad07355d-b613-4236-b7d9-241b35a08da0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "ATAZANAVIR SULFATE",
  "productndc": "0003-3638",
  "dosage_form": "POWDER",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA206352",
  "marketing_category": "NDA"
}

See everything about atazanavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.